Sort
30,917 grants matching “tumor microenvironment”
Tumor Microenvironment Determinants of TKI Response in Oncogene-Driven Lung Cancer
$279,465Erin L Schenk · University Of Colorado Denver · K08 · FY2025 · CA
Tumor Microenvironment Determinants of TKI Response in Oncogene-Driven Lung Cancer
$279,465Erin L Schenk · University Of Colorado Denver · K08 · FY2024 · CA
Radiation modulation of cell plasticity programs determine prostate cancer oligometastatic potential
$279,450Phuoc T. Tran · University Of Maryland Baltimore · U54 · FY2023 · CA
Tumor Induced Dysregulation of T Cell Immunity
$279,427James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
New Patient-derived MicroTumor Culture/Assay System
$279,406Raj Singh · Vivo Biosciences, Inc. · N43 · FY2013 · CA
The Role of Monocytes in non-Hodgkin Lymphoma
$279,404Stephen M Ansell · University Of Iowa · P50 · FY2016 · CA
THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY
$279,400Rongfu Wang · Baylor College Of Medicine · P01 · FY2010 · CA
MUC1 Roles in ovarian cancer pathogenesis and immune therapy
$279,390Anda M Vlad · Magee-Women'S Res Inst And Foundation · R01 · FY2014 · CA
Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cel
$279,388Teresa W-M Fan · University Of Kentucky · P01 · FY2015 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$279,366Constantinos Koumenis · University Of Pennsylvania · R01 · FY2015 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$279,366Constantinos Koumenis · University Of Pennsylvania · R01 · FY2016 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$279,366Constantinos Koumenis · University Of Pennsylvania · R01 · FY2012 · CA
Vascular Maintenance and Brain Tumor Refractory
$279,350Vanderbilt University · R01 · FY2005 · NS
CHIMERIC T CELLS TARGETING NEUROBLASTOMA
$279,346Malcolm K Brenner · Baylor College Of Medicine · P01 · FY2010 · CA
Imaging and Identification of Micro-Environments Eliciting Mammary Tumor Cell Mig
$279,333John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2013 · CA
Targeting immunosuppression blockade to T cells for cancer immunotherapy
$279,329Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2017 · CA
Overcoming Tumor Evasion in EBV+ve Lymphomas
$279,303Cliona M Rooney · Baylor College Of Medicine · P50 · FY2018 · CA
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival
$279,300Susan L Bellis · University Of Alabama At Birmingham · R01 · FY2015 · GM
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival
$279,300Susan L Bellis · University Of Alabama At Birmingham · R01 · FY2014 · GM
The oncogenic basis of Bmi-1 in neuroblastoma development
$279,300Han-Fei Ding · Augusta University · R01 · FY2010 · CA
The oncogenic basis of Bmi-1 in neuroblastoma development
$279,300Han-Fei Ding · Augusta University · R01 · FY2009 · CA
Glycosylation-dependent mechanisms regulating ovarian tumor cell survival
$279,300Susan L Bellis · University Of Alabama At Birmingham · R01 · FY2016 · GM
Administrative Core
$279,284Forest M White · Massachusetts Institute Of Technology · U54 · FY2020 · CA
Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2)
$279,259Robert Loberg · University Of Michigan At Ann Arbor · P50 · FY2009 · CA
Safety and Efficacy of Vemurafenib and High-Dose InterferonAlpha-2b for Advanced Melanoma
$279,210Soldano Ferrone · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA